SPARC Share Price | Under the terms of the LoI, SPARC will receive a 55% equity stake in Tiller Therapeutics, with equity vesting in two tranches. The first 45% will vest upon the execution of the licence agreement, while the remaining 10% will vest upon achieving certain milestones or within six months of the agreement.
